https://www.selleckchem.com/products/ml-7.html
The understanding of malperfusion syndromes has also expanded significantly, including recommendations for surgical delay. Finally, approaches to triage have been significantly influenced by resource limitations related to the ongoing COVID-19 pandemic. While medical management remains a reasonable option in carefully selected patients at prohibitive risk for open surgery, endovascular therapies for treatment of ATAAD are rapidly evolving. Early surgical repair remains the preferred treatment for most patients with ATAAD, however, improvem
Like
Comment
Share
